Continuous peripheral nerve block has been shown to be superior to traditional opioid-based analgesia in terms of improved analgesia with reduced sedation, nausea, pruritis, and hospital stay. Because ...
The global continuous peripheral nerve block catheter market is anticipated to record a CAGR of 6.1% and the market is estimated to reach a value of US$ 742.7 Mn in 2027 from a valuation of around US$ ...
The Continuous Peripheral Nerve Block Catheter Market is predicted to grow at a 6.1% CAGR and is projected to reach US$ 742.7 million By 2027 from an estimated US$ 411 million in 2017. Future Market ...
NEWARK, Del, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The continuous peripheral nerve block catheter market is estimated to be worth US$ 585.6 million in 2023 and projected to be valued at US$ 1,058.6 ...
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care ...
ORLANDO, Fla. — Suprascapular nerve block has been shown efficacious in both outpatient shoulder arthroscopy and inpatient shoulder surgery. In addition, the technique avoids some of the problems ...
In both studies, Exparel achieved a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine hydrochloride. The Food and Drug Administration (FDA) has ...
A nerve block, or neural blockade, is a method of producing anesthesia — a loss of feeling used to prevent or control pain. Nerve blocks can be surgical or nonsurgical. Nonsurgical nerve blocks ...
WOLF CREEK, MT / ACCESSWIRE / February 22, 2022 / Solo-Dex, Inc. today announced a national distribution agreement for its proprietary continuous peripheral nerve block catheters with InfuSystem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback